This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/usa/520090-biden-admin-stops-astrazeneca-factory/
The article has changed 4 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| Biden admin stops AstraZeneca/Vaxzevria production in Baltimore, J&J put in charge after ‘error’ spoils 15mn doses – reports | Biden admin stops AstraZeneca/Vaxzevria production in Baltimore, J&J put in charge after ‘error’ spoils 15mn doses – reports |
| (5 months later) | |
| Vaxzevria (AstraZeneca) Covid-19 vaccine reportedly will no longer be produced in a Baltimore factory after workers accidentally mixed ingredients with Johnson & Johnson’s vaccine, spoiling 15 million doses. | Vaxzevria (AstraZeneca) Covid-19 vaccine reportedly will no longer be produced in a Baltimore factory after workers accidentally mixed ingredients with Johnson & Johnson’s vaccine, spoiling 15 million doses. |
| The US Department of Health & Human Services has given Johnson & Johnson full responsibility of the Emergent BioSolutions facility following the error to avoid such an accident again, and Vaxzevria (previously known as AstraZeneca) is now looking for a new production place, according to an unnamed health official who spoke to the New York Times. | The US Department of Health & Human Services has given Johnson & Johnson full responsibility of the Emergent BioSolutions facility following the error to avoid such an accident again, and Vaxzevria (previously known as AstraZeneca) is now looking for a new production place, according to an unnamed health official who spoke to the New York Times. |
| The official told the Times that Johnson & Johnson will now be the only vaccine manufacturer in charge of the facility in a move that “is meant to avoid future mix-ups.” J&J is said to confirm the decision. | The official told the Times that Johnson & Johnson will now be the only vaccine manufacturer in charge of the facility in a move that “is meant to avoid future mix-ups.” J&J is said to confirm the decision. |
| It was reported this week that human error had led to the mix-up of the two vaccines’ ingredients, ruining the batch of 15 million doses, though the affected vaccines were soon quarantined. | It was reported this week that human error had led to the mix-up of the two vaccines’ ingredients, ruining the batch of 15 million doses, though the affected vaccines were soon quarantined. |
| According to the New York Times, “one or more workers somehow confused the two” vaccine ingredients during production in February and the error “went undiscovered for days until Johnson & Johnson’s quality control checks uncovered it,” and a federal investigation was launched. | According to the New York Times, “one or more workers somehow confused the two” vaccine ingredients during production in February and the error “went undiscovered for days until Johnson & Johnson’s quality control checks uncovered it,” and a federal investigation was launched. |
| “This batch was never advanced to the filling and finishing stages of our manufacturing process,” J&J said in a statement. | “This batch was never advanced to the filling and finishing stages of our manufacturing process,” J&J said in a statement. |
| The Johnson & Johnson single-dose vaccine is one of the latest to be approved for use in both the United States and European Union. Johnson & Johnson has promised to supply the US government with at least 100 million vaccine doses by late May. | The Johnson & Johnson single-dose vaccine is one of the latest to be approved for use in both the United States and European Union. Johnson & Johnson has promised to supply the US government with at least 100 million vaccine doses by late May. |
| Meanwhile AstraZeneca’s jab – which has recently been renamed Vaxzevria and has not yet been approved by the US – has experienced many difficulties, including a ban in some EU countries after investigations linked the vaccine to rare blood clots. | Meanwhile AstraZeneca’s jab – which has recently been renamed Vaxzevria and has not yet been approved by the US – has experienced many difficulties, including a ban in some EU countries after investigations linked the vaccine to rare blood clots. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |